Naftopidil

CHEMBL142635 Phase 4 अनुमोदित Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
392.5 g/mol
LogP
4.1
Phase
4

An alpha-1 adrenergic receptor blocker used in Japan and other Asian countries to treat benign prostatic hyperplasia, relieving urinary symptoms by relaxing smooth muscle in the prostate and bladder neck. It may also have benefits for sexual function.

आणविक भार

392.5000 g/mol

LogP

4.10

TPSA

45.20 Ų

लिपिंस्की RO5

उत्तीर्ण

चिकित्सीय क्षेत्र

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D संरचना

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

COc1ccccc1N1CCN(CC(O)COc2cccc3ccccc23)CC1

InChI

InChI=1S/C24H28N2O3/c1-28-24-11-5-4-10-22(24)26-15-13-25(14-16-26)17-20(27)18-29-23-12-6-8-19-7-2-3-9-21(19)23/h2-12,20,27H,13-18H2,1H3

Molecular Formula

C24H28N2O3

HBD / HBA

1 / 5

घूर्णनीय बंधन

7

भारी परमाणु

29

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

अक्सर पूछे जाने वाले प्रश्न

An alpha-1 adrenergic receptor blocker used in Japan and other Asian countries to treat benign prostatic hyperplasia, relieving urinary symptoms by relaxing smooth muscle in the prostate and bladder neck. It may also have benefits for sexual function.

Yes, Naftopidil is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL142635. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4418. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

चिकित्सा अस्वीकरण

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.